Senvest Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Senvest Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-781,325	Closed	-$32.4M	–	82
2020 Q3	$32.4M	Sell	781,325 -83,020	-10%	-$3.81M	1.84%	22
2020 Q2	$41.4M	Sell	864,345 -213,946	-20%	-$16.5M	2.58%	15
2020 Q1	$67.9M	Sell	1,078,291 -140,830	-12%	-$12.7M	7.95%	4
2019 Q4	$151M	Buy	1,219,121 +48,211	+4%	+$4.32M	10.27%	3
2019 Q3	$77.7M	Buy	1,170,910 +144,522	+14%	+$9.7M	6.7%	5
2019 Q2	$81.7M	Buy	1,026,388 +364,188	+55%	+$32.6M	7.17%	4
2019 Q1	$74.1M	Buy	+662,200	New	+$72.4M	5.56%	4
2018 Q3	–	Sell	-976,127	Closed	-$81.9M	–	53
2018 Q2	$81.9M	Sell	976,127 -175,905	-15%	-$12.9M	5.65%	6
2018 Q1	$70.9M	Buy	1,152,032 +181,106	+19%	+$10.9M	5.4%	5
2017 Q4	$56.7M	Buy	970,926 +387,136	+66%	+$24.4M	4%	7
2017 Q3	$33.9M	Buy	+583,790	New	+$62.9M	2.23%	17

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Senvest Management's ICPT Position: Q4 2020 in Review

Senvest Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 781,325 shares — an estimated $32.4M sold.

Senvest Management first reported a position in ICPT in Q3 2017 and held it in 11 quarters. The position peaked at $151M in Q4 2019. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

Senvest Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Senvest Management sold 781,325 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $32.4M.
Senvest Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 11 quarters.
Senvest Management's Intercept Pharmaceuticals, Inc. position peaked at $151M in Q4 2019.
175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Senvest Management's 13F filing for Q4 2020, filed 12 Feb 2021.